Showing results (51-60 of 74) with videos related to
Sort By:
Pageof 8
Journal of Thrombosis and Haemostasis : JTH|April 16, 2013
Bleeding risk in warfarinized patients with a therapeutic international normalized ratio: the effect of low factor IX levelsY Dargaud, M Hoffman, L Lefrapper, et al.Journal of Thrombosis and Haemostasis : JTH|June 29, 2004
Two novel mutations in EGF-like domains of human factor IX dramatically impair intracellular processing and secretionN Enjolras, J-L Plantier, M-H Rodriguez, et al.Journal of Thrombosis and Haemostasis : JTH|November 18, 2006
Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastographyL Rugeri, A Levrat, J S David, et al.British Journal of Haematology|November 1, 1996
A nonsense mutation in the GPIIb heavy chain (Ser 870-->stop) impairs platelet GPIIb-IIIa expressionC Vinciguerra, A Khelif, M Alemany, et al.Journal of Thrombosis and Haemostasis : JTH|February 24, 2017
Personalized thromboprophylaxis using a risk score for the management of pregnancies with high risk of thrombosis: a prospective clinical studyY Dargaud, L Rugeri, C Fleury, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|March 4, 2016
Recombinant long-acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trialsC Negrier, G Young, F Abdul Karim, et al.Journal of Thrombosis and Haemostasis : JTH|November 25, 2003
Monitoring the bioavailability of FEIBA with a thrombin generation assayK Váradi, C Negrier, E Berntorp, et al.Journal of Thrombosis and Haemostasis : JTH|August 2, 2016
Study of six patients with complete F9 deletion characterized by cytogenetic microarray: role of the SOX3 gene in intellectual disabilityY Jourdy, N Chatron, M-L Carage, et al.European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
Phase I study of interleukin-6 in children with solid tumours in relapseE Bouffet, T Philip, C Negrier, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|March 5, 2003
Continuous intravenous infusion of a plasma-derived factor IX concentrate (Mononine) in haemophilia BW K Hoots, C Leissinger, S Stabler, et al.Pageof 8